Literature DB >> 16183622

Interpreting the trail making test following traumatic brain injury: comparison of traditional time scores and derived indices.

Rael T Lange1, Grant L Iverson, Martin J Zakrzewski, Patrick E Ethel-King, Michael D Franzen.   

Abstract

The purpose of this study was to examine the clinical application of traditional time scores and various derived indices from the Trail Making Test (TMT) in a sample of 571 patients with acute traumatic brain injury (TBI). Participants were classified into four injury severity groups. A clear linear relation between injury severity and TMT performance was demonstrated, with the more severely brain injured patients performing more poorly on most measures. Hierarchical logistic regression analysis of TMT time scores across binary extreme groups based on injury severity resulted in high classification rates for patients with very mild TBI (93.0% correctly classified) and low classification rates for patients with moderate to severe TBI (50.0% correctly classified). However, TMT derived indices did not provide a unique contribution to test interpretation beyond what is already available from Part A and B separately.

Entities:  

Mesh:

Year:  2005        PMID: 16183622     DOI: 10.1080/1380339049091290

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  13 in total

1.  Operating characteristics of executive functioning tests following traumatic brain injury.

Authors:  Jason A Demery; Michael J Larson; Neha K Dixit; Russell M Bauer; William M Perlstein
Journal:  Clin Neuropsychol       Date:  2010-11       Impact factor: 3.535

2.  Trail Making Test error analysis in classic motor neuron disease.

Authors:  Foteini Christidi; Evangelia Kararizou; Nikolaos I Triantafyllou; George P Paraskevas; Ioannis Zalonis
Journal:  Neurol Sci       Date:  2012-11-18       Impact factor: 3.307

3.  What cognitive abilities are involved in trail-making performance?

Authors:  Timothy A Salthouse
Journal:  Intelligence       Date:  2011-07

4.  The Trail Making Test in prodromal Huntington disease: contributions of disease progression to test performance.

Authors:  Justin J F O'Rourke; Leigh J Beglinger; Megan M Smith; James Mills; David J Moser; Kelly C Rowe; Douglas R Langbehn; Kevin Duff; Julie C Stout; Deborah L Harrington; Noelle Carlozzi; Jane S Paulsen
Journal:  J Clin Exp Neuropsychol       Date:  2011-02-07       Impact factor: 2.475

5.  Rey Tangled Line Test: A measure of processing speed in TBI.

Authors:  Annie-Lori C Joseph; Hope A Peterson; Katelyn M Garcia; Shannon M McNally; Tracyann K Mburu; Sara M Lippa; John Dsurney; Leighton Chan
Journal:  Rehabil Psychol       Date:  2019-06-27

6.  Premature cognitive decline in specific domains found in young veterans with mTBI coincide with elder normative scores and advanced-age subjects with early-stage Parkinson's disease.

Authors:  Vicki A Nejtek; Rachael N James; Michael F Salvatore; Helene M Alphonso; Gary W Boehm
Journal:  PLoS One       Date:  2021-11-17       Impact factor: 3.240

7.  Multicomponent analysis of a digital Trail Making Test.

Authors:  Robert P Fellows; Jessamyn Dahmen; Diane Cook; Maureen Schmitter-Edgecombe
Journal:  Clin Neuropsychol       Date:  2016-10-03       Impact factor: 3.535

8.  The Effects of Aging, Malingering, and Traumatic Brain Injury on Computerized Trail-Making Test Performance.

Authors:  David L Woods; John M Wyma; Timothy J Herron; E William Yund
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

9.  Outcome from Complicated versus Uncomplicated Mild Traumatic Brain Injury.

Authors:  Grant L Iverson; Rael T Lange; Minna Wäljas; Suvi Liimatainen; Prasun Dastidar; Kaisa M Hartikainen; Seppo Soimakallio; Juha Ohman
Journal:  Rehabil Res Pract       Date:  2012-04-19

10.  Neuropsychological outcome and diffusion tensor imaging in complicated versus uncomplicated mild traumatic brain injury.

Authors:  William J Panenka; Rael T Lange; Sylvain Bouix; Jason R Shewchuk; Manraj K S Heran; Jeffrey R Brubacher; Ryan Eckbo; Martha E Shenton; Grant L Iverson
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.